View in EDS HTML Full Text PDF Full Text

CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial.

Saved in:
Bibliographic Details
Title: CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial.
Authors: Benza, Raymond L.1 (AUTHOR) chenza.consulting@gmail.com, Adamson, Philip B.2 (AUTHOR), Bhatt, Deepak L.3 (AUTHOR), Frick, Fredrik4 (AUTHOR), Olsson, Gunnar5 (AUTHOR), Bergh, Niklas5,6 (AUTHOR), Dahlöf, Björn4,5 (AUTHOR)
Source: Pulmonary Circulation. Jan2024, Vol. 14 Issue 1, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 176294951
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Benza%2C+Raymond+L%2E%22">Benza, Raymond L.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> chenza.consulting@gmail.com</i><br /><searchLink fieldCode="AR" term="%22Adamson%2C+Philip+B%2E%22">Adamson, Philip B.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bhatt%2C+Deepak+L%2E%22">Bhatt, Deepak L.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Frick%2C+Fredrik%22">Frick, Fredrik</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Olsson%2C+Gunnar%22">Olsson, Gunnar</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Bergh%2C+Niklas%22">Bergh, Niklas</searchLink><relatesTo>5,6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dahlöf%2C+Björn%22">Dahlöf, Björn</searchLink><relatesTo>4,5</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Pulmonary+Circulation%22">Pulmonary Circulation</searchLink>. Jan2024, Vol. 14 Issue 1, p1-16. 16p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=176294951
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/pul2.12323
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 16
        StartPage: 1
    Titles:
      – TitleFull: CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Benza, Raymond L.
      – PersonEntity:
          Name:
            NameFull: Adamson, Philip B.
      – PersonEntity:
          Name:
            NameFull: Bhatt, Deepak L.
      – PersonEntity:
          Name:
            NameFull: Frick, Fredrik
      – PersonEntity:
          Name:
            NameFull: Olsson, Gunnar
      – PersonEntity:
          Name:
            NameFull: Bergh, Niklas
      – PersonEntity:
          Name:
            NameFull: Dahlöf, Björn
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: Jan2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 20458932
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Pulmonary Circulation
              Type: main
ResultId 1